SAN FRANSCISCO, November 8, 2016 /PRNewswire/ --
The global immunoassay instruments/analyzers market was valued at USD 14.7 billion in 2015 and is expected to reach a value of USD 23.3 billion by 2024. The prime factors driving the immunoassay analyzers market growth include constant introduction of advanced products. In addition,
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
The industry is rapidly growing due to the constant introduction and adoption of automated as well as advanced techniques for laboratory instruments and analyzers in developed countries. Rising prevalence of infectious diseases and chronic conditions, which require early diagnosis, prevention, and treatment, is one of the main factors boosting the demand for immunoassay analyzers and compact consumable products in the healthcare sector. In addition, industry is gaining speed with the launch of innovative products such as compact and portable ichroma II of Boditech Med, Inc., which is an FDA-approved fluorescence scanning instrument. Moreover, with the U.S. FDA approval of the iStat cardiac Troponin I test cartridge that uses enzyme-linked immunosorbant assay (ELISA) method, commercialization of such immunoassay products is also expected to increase significantly over the next few years.
In North America, the government authorities and private companies have significantly contributed toward development of technology, supported research funding, and helped in commercialization of immunoassay analyzers and associated instruments. For instance, in June 2016, Abbott diagnostic launched Architect i1000SR, an automated immunoassay instrument that works on the principle of chemiluminescence. Using this system, number of different assays can be performed in a very short time
Browse full research report with TOC on "Immunoassay Instruments/Analyzers Market Revenue Analysis by Product (Chemiluminescence, Immunofluorescence analyzers, Radioimmunoassay, ELISA), by Application (Oncology, Infectious Disease Testing, Autoimmune Disease), and Segment Forecasts to 2024" at: http://www.grandviewresearch.com/industry-analysis/immunoassay-instruments-analyzers-market
Further Key Findings from the Study Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the immunoassay instruments/analyzers market by product, application, and region:
Access research insight: http://www.grandviewresearch.com/research-insights/immunoassay-instruments-market-insights
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - http://www.grandviewresearch.com/blogs/healthcare
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: email@example.com Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...
Rosacea is a chronic skin condition marked by facial redness and swelling especially around the ...
Immunotherapy is a type of treatment method that works by using certain components of a person's ...View All